Results 161 to 170 of about 2,581,635 (319)
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
<i>N</i>-Chlorination of Sulfonamides: DFT Study of the Reaction Mechanism. [PDF]
Ljulj A +3 more
europepmc +1 more source
Explicit lower bounds for linear forms in two logarithms [PDF]
Nicolas Gouillon
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
The Effect of Implicit vs. Explicit Instruction on Learning Form-based vs. Meaning-based Language Features [PDF]
Wang Jing
openalex
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source
Delayed Signaling in Mitotic Checkpoints: Biological Mechanisms and Modeling Perspectives. [PDF]
Ibrahim B.
europepmc +1 more source
Note on explicit form of entanglement entropy in the Russo-Susskind-Thorlacius model [PDF]
Myungseok Eune, Yongwan Gim, Wontae Kim
openalex +1 more source
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath +13 more
wiley +1 more source

